Essential medicines for cancer: WHO recommendations and national priorities

Author:

Robertson Jane1,Barr Ronald2,Shulman Lawrence N3,Forte Gilles B4,Magrini Nicola4

Affiliation:

1. School of Medicine and Public Health, The University of Newcastle, Newcastle, Australia.

2. Departments of Pediatrics, Pathology and Medicine, McMaster University, Hamilton, Canada.

3. Center for Global Cancer Medicine, University of Pennsylvania, Philadelphia, United States of America.

4. Department of Essential Medicines and Health Products, World Health Organization, 20 avenue Appia, 1211 Geneva 27, Switzerland.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference31 articles.

1. Global challenges in pediatric oncology.;Rodriguez-Galindo;Curr Opin Pediatr,2013

2. Access to cancer medicine in low-resource settings.;Lancet Oncol,2013

3. Van den Ham R, Bero L, Laing R. The world medicines situation 2011: selection of essential medicines. Geneva: World Health Organization; 2011. Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js18770en/ [cited 2015 May 25].

4. Essential drugs for cancer chemotherapy: memorandum from a WHO meeting.;Bull World Health Organ,1985

5. Essential drugs for cancer chemotherapy: WHO consultation.;Bull World Health Organ,1994

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3